ECONOMIC AND SOCIAL IMPACTS Rescheduling marijuana to Schedule V can significantly benefit minority communities by creating more opportunities in the legal cannabis industry, fostering economic growth, and reducing disparities. Additionally, this rescheduling would facilitate more extensive research into marijuana's therapeutic potentials, leading to new medical products and treatments. COMPLIANCE WITH INTERNATIONAL OBLIGATIONS Rescheduling marijuana to Schedule V ensures that the United States remains compliant with international treaty obligations. This balance allows for domestic regulatory flexibility without compromising international commitments. EIGHT STEP PROCESS FOR RESCHEDULING 21 U.S.C. 811 To reschedule marijuana to Schedule V, the following eight factors must be considered: 1. Potential for Abuse: Marijuana has a low potential for abuse relative to substances in Schedule IV. 2. Scientific Evidence of Pharmacological Effect: Evidence supports marijuana's efficacy in treating various medical conditions. 3. Current Scientific Knowledge: There is extensive scientific knowledge about marijuana's effects and medical uses. 4. History and Pattern of Abuse: The abuse pattern of marijuana is less severe than that of higher-scheduled drugs. 5. Scope and Significance of Abuse: The overall public health impact of marijuana abuse is relatively low. 6. Risk to Public Health: Marijuana poses a lower risk to public health compared to higher-scheduled substances. 7. Dependence Liability: Marijuana's potential for dependence is low, supporting a Schedule V classification. 8. Immediate Precursor: Marijuana is not an immediate precursor of any substance already controlled under the CSA. CONCLUSION Rescheduling marijuana to Schedule V is supported by its lower potential for abuse, recognized medical use, limited dependence liability, and manageable public health risks. This change would facilitate broader access for medical purposes while maintaining appropriate regulatory controls, benefiting public health and supporting economic growth, particularly in minority communities. I urge the DEA to consider these points and proceed with rescheduling marijuana to Schedule V to reflect its therapeutic benefits and lower abuse potential.
Thank you for considering my comments
Sincerely,
[Your Name]
Members and advocates can use this letter as a template to submit their comments to the DEA Rules Making public comment site at regulations.gov.
PAGE 18
Made with FlippingBook - professional solution for displaying marketing and sales documents online